atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference
NEW YORK and BERLIN, Feb. 28, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming […]
TSX News -
WSP Reports Strong 2023 Results and Outlook for 2024
2023 ACCOMPLISHMENTS: Strong results in the high end of Management’s revised outlook range Net revenue up 22% or nearly $2B […]
TSX News -
Savaria Announces Date for Fourth Quarter 2023 Financial Results
LAVAL, Quebec, Feb. 28, 2024 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS) one of the global leaders in the […]
HII Hosts Merging Vets & Players Event at Newport News Shipbuilding
NEWPORT NEWS, Va., Feb. 28, 2024 (GLOBE NEWSWIRE) — HII (NYSE: HII) today hosted the nonprofit Merging Vets and Players […]
Portillo’s Inc. Announces Offering of Class A Common Stock in “Synthetic Secondary” Transaction
CHICAGO, Feb. 28, 2024 (GLOBE NEWSWIRE) — Portillo’s Inc. (“Portillo’s” or the “Company”) (Nasdaq: PTLO), the fast-casual restaurant concept known […]
ClearPoint Neuro Launches Proposed Public Offering of Common Stock
SOLANA BEACH, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, […]
CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update
Gilead Sciences, Inc. has proposed to acquire CymaBay for $32.50 per share in cash or a total equity value of […]
ThreeD Capital Inc. Amends Investor Relations Agreement
TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture […]
Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
MONTREAL and CHARLOTTE, N.C., Feb. 28, 2024 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical company focused on the […]
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
ROCKVILLE, Md., Feb. 28, 2024 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and […]
